Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Immunotherapy Integrated Research Center (IIRC) at Fred Hutch is seeking a PhD level Director to lead a new initiative advancing the introduction and development of new technologies. The Advanced Technology Lab will be a newly constituted resource with a mission to spur in-house development and early adaptation of novel technologies. Technologies of greatest utility to immuno-oncology research will be targeted, including advanced single cell RNA sequencing techniques, T- and B-cell receptor sequencing, and other DNA/RNA-based technologies. The incumbent will also actively seek out new technologies, through contacts with academic and industry labs. The Director will work closely with computational biologists to develop data analysis methods for newly developed technologies.
As a Fred Hutch strategic initiative, we value inclusion and a diversity of backgrounds and perspectives to inform our work. We believe in supporting each other through mentorship and providing resources for professional development. Given these values, we strive to make our recruitment and promotion processes fair and transparent. Therefore, we strongly encourage all individuals with an interest in the position to apply.